Page last updated: 2024-11-06

sodium selenide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Sodium selenide (Na2Se) is an inorganic compound with the formula Na2Se. It is a gray-black solid that is highly reactive with water and air. It is typically synthesized by reacting sodium with selenium under an inert atmosphere. Sodium selenide is used as a precursor to other selenium compounds, such as selenides and selenites. It is also used as a reagent in organic chemistry and in the production of semiconductor materials. Sodium selenide is studied because it is a potential source of selenium, an essential trace element for human health. It is also of interest for its potential applications in nanotechnology and energy storage.'

Cross-References

ID SourceID
PubMed CID73973
CHEBI ID77773
MeSH IDM0113077

Synonyms (22)

Synonym
sodium selenide ,
disodium monoselenide
einecs 215-212-0
sodium selenide (na2se)
disodium selenide
1313-85-5
1313-86-6
unii-1fek1k7wce
1fek1k7wce ,
selenide sodium
sodium selenide [mi]
selenide sodium [who-dd]
na2se
CHEBI:77773
DTXSID5061661
VPQBLCVGUWPDHV-UHFFFAOYSA-N
Q418425
disodium;selenium(2-)
seleniuro di sodio
seleniure de sodium
seleniuro de sodio
seleneto de sodio

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" However, few experiments studied the direct link between this toxic agent and cell death."( Sodium selenide toxicity is mediated by O2-dependent DNA breaks.
Beuneu, F; Blanquet, S; Dauplais, M; Decourty, L; Jacquier, A; Lazard, M; Malabat, C; Peyroche, G; Plateau, P; Saveanu, C, 2012
)
1.82

Dosage Studied

ExcerptRelevanceReference
" Additionally, full bioactivity was retained at the alpha7 nicotinic acetylcholine receptor, with each selenoanalogue exhibiting a dose-response curve that overlaps with wild-type ImI, thus further supporting an isomorphic structure."( Alpha-selenoconotoxins, a new class of potent alpha7 neuronal nicotinic receptor antagonists.
Adams, DJ; Alewood, PF; Armishaw, CJ; Craik, DJ; Daly, NL; Nevin, ST, 2006
)
0.33
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
reducing agentThe element or compound in a reduction-oxidation (redox) reaction that donates an electron to another species.
poisonAny substance that causes disturbance to organisms by chemical reaction or other activity on the molecular scale, when a sufficient quantity is absorbed by the organism.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
inorganic sodium salt
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (25)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (24.00)18.7374
1990's8 (32.00)18.2507
2000's5 (20.00)29.6817
2010's4 (16.00)24.3611
2020's2 (8.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 42.80

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index42.80 (24.57)
Research Supply Index3.30 (2.92)
Research Growth Index4.62 (4.65)
Search Engine Demand Index59.94 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (42.80)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other26 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]